All lobbying filings
BALLARD PARTNERS
BALLARD PARTNERS filed a Q2 termination report for GENETIX BIOTHERAPEUTICS INC. on October 16, 2026, reporting $80,000 in lobbying income.
Lobbying for GENETIX BIOTHERAPEUTICS INC. · Biotechnology company
Filing · LD-2 quarterly report
Q2 termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Oct 16, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Representation ended
May 31, 2026
The registrant reported terminating its work for this client.
Lobbyists on this filing
2
-
ALISON ANWAYPreviously held: LA to Senator Pat Roberts 2006-2010
-
TOLA THOMPSONPreviously held: Communications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021)
Government bodies contacted
3
Lobbying activity
1
Advocacy regarding an FDA issue.